Octagon Capital Advisors LP - Jun 30, 2025 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value

Filing Manager
Octagon Capital Advisors LP
Reporting Manager
Octagon Capital Advisors LP
Security
Unicycive Therapeutics, Inc. Common Stock, $0.001 par value
Shares outstanding
12.8M shares
Disclosed Ownership
1M shares
Ownership
7.8%
Form type
SCHEDULE 13G/A
Date filed
8/12/2025, 04:05 PM
Date of event
Jun 30, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Octagon Capital Advisors LP 7.8% 1M 0 1M /s/ Ting Jia Managing Member
Octagon Investments Master Fund LP 5.1% 650K 0 650K /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Octagon Private Opportunities Fund II LP 2.7% 350K 0 350K /s/ Ting Jia Managing Member, Octagon Investments GP, LLC, its general partner
Ting Jia 7.8% 1M 0 1M /s/ Ting Jia Ting Jia